Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation

Liver Transplantation

Volumn 9, Issue 10, 2003, Pages 1053-1061

  Saab, Sammy ^a   Chang, Albert J ^a   Comulada, Scott ^a   Geevarghese, Sunil K ^b   Anselmo, R Dean M ^a   Durazo, Francisco ^a   Han, Steven ^a   Farmer, Douglas G ^a   Yersiz, Hasan ^a   Goldstein, Leonard I ^a   Ghobrial, R Mark ^a   Busuttil, Ronald W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS C ANTIBODY; LAMIVUDINE; METHYLPREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOPROPHYLAXIS; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OUTCOMES RESEARCH; PATIENT SELECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECIPIENT; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 10744230936     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2003.50208     Document Type: Article

References (31)

1. Thalheimer U, Capra F. Liver transplantation: making the best out of what we have. Dig Dis Sci 2002;47:945-953.
2. Castells L, Vargas V, Rodriguez-Frias F, Allende H, Jardi R, Mararit C, et al. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Transplant Proc 1999;31:2464-2465.
3. Uemoto S, Inomata Y, Sannomiya A, Koshiba T, Kurokawa T, Takatsuki M, et al. Posttransplant hepatitis B infection in liver transplantation with hepatitis B core antibody-positive donors. Transplant Proc 1998;30:134-135.
4. Nery JR, Gedaly R, Vianna R, Berho M, Weppler D, Levi D, et al. Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? Transplant Proc 2001;33:1521-1522.
5. Joya-Vazquez P, Dodson F, Dvorchik I, Gray E, Chesky A, Demetris A, et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation 2002;73:1598-1602.
6. Loss G, Mason A, Blazek J, Dick D, Lipscomb J, Guo L, et al. Transplantation of livers from HbcAb positive donors into HbcAb negative recipients: A strategy and preliminary results. Clin Transplantation 2001;15:55-58.
7. Boyacioglu S, Arslan H, Demirhan B, Gur G, Tuan M, Haberal M. Is there risk of transmitting hepatitis B virus in accepting hepatitis b core antibody-positive donors for living related liver transplantation? Transplant Proc 2001;33:2802-2803.
8. Anselmo D, Ghobrial R, Lee J, Weaver M, Cao C, Saab S, et al. New era of liver transplantation for hepatitis B: A 17-year single-center experience. Ann Surg 2002;235:611-620.
9. Salizzoni M, Lupo F, Zamboni F, Franchello A, Lavezzo B, Cerutti E, Strignano P. Outcome of patients transplanted with liver from hepatitis C positive donors. Transplant Proc 2001;33: 1507-1508.
10. Vargas HE, Laskus T, Wang LF, Lee R, Radkowski M, Dodson F, et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999;117:149-153.
11. Velidedeoglu, E, Desai N, Campos L, Olthoff K, Shaked A, Nunes F, et al. Effect of donor hepatitis C on liver graft survival. Transplant Proc 2001;33:3795-3796.
12. Testa G, Goldstein RM, Netto G, Abbasoglu O, Brooks BK, Levy MF, et al. Long-term outcome of patients transplanted with livers from hepatitis C-positive donors. Transplantation 1998; 65:925-929.
13. Marroquin CE, Marino G, Kuo PC, Plotkin JS, Rustgi VK, Lu AD, et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001;7:762-768.
14. Ghobrial R, Steadman R, Gornbein J, Lassman C, Holt C, Chen P, et al. A 10-year experience of liver transplantation for hepatitis C: Analysis of factors determining outcome in over 500 patients. Ann Surg 2001;234:384-394.
15. Saab S, Ghobrial RM, Han S, Chen P, Farmer DG, Yersiz H, et al. Hepatitis C infected grafts may be used in orthotopic liver transplantation: A matched analysis. Am J Transplant 2002;2: 1127.
16. Kizilisik TA, Al-Sebayel M, Hammad A, Al-Traif I, Ramirez CG, Abdulla A. Hepatitis C recurrence n live transplant recipients. Transplant Proc 1997;29:2875-2877.
17. Konig V, Bauditz J, Lobeck H, Lusebrink R, Neuhaus P, Blumhardt G, et al. Hepatitis C virus reinfection in allografts after orthotopic liver transplantation. Hepatology 1992;16:1137-1143.
18. Lake JR, Wright T, Ferrell L, Donegan E, Roberts J, Ascher N. Hepatitis C and B in liver transplantation. Transplant Proc 1993;25:2006-2009.
19. Arnold JC, Kraus T, Otto G, Muller HM, Hofmann W, Gmelin K, et al. Recurrent hepatitis C virus infection after liver transplantation. Transplant Proc 1992;24:2646-2647.
20. Wright TL, Donegan E, Hsu HH, Ferrell L, Lake JR, Kim M, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.
21. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-1520.
22. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
23. Munoz S. Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl 2002;8:S82-S87.
24. Di Bisceglie AM: Liver transplantation for hepatitis C: The promise and the challenge. Hepatology 1995;22:660-662.
25. Ascher NL, Lake JR, Emond J, Roberts J. Liver transplantation for hepatitis C virus-related cirrhosis. Hepatology 1994;20:24S-27S.
26. Belle SH, Beringer KC, Detre KM. Recent findings concerning liver transplantation in the United States. Clin Transpl 1996;15-29.
27. Gane EJ, Portmann BC, Naoumov NV, Smith HM, Underhill JA, Donaldson PT, et al: Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334: 815-820.
28. Charlton M, Seaberg E, Wiesner R, Everhar J, Zetterman R, Lake J, et al: Predictors of patient and graft survival after liver transplantation for hepatitis C. Hepatology 1998;28:823-830.
29. Ghobrial RM, Farmer DG, Baquerizo A, Colquhoun S, Rosen HR, Yersiz H, et al: Orthotopic liver transplantation for hepatitis C: Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-centerexperience. Ann Surg 1999;229:824-831.
30. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896.
31. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, et al: Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. Hepatology 2002;36:202-210.